PolyPeptide Group AG (SWX:PPGN)
Switzerland · Delayed Price · Currency is CHF 22.50
+0.45 (2.04%)
Jul 21, 2025, 5:30 PM CET
PolyPeptide Group AG Revenue
In the year 2024, PolyPeptide Group AG had annual revenue of 336.79M EUR with 5.13% growth. PolyPeptide Group AG had revenue of 201.75M in the half year ending December 31, 2024, with 36.94% growth.
Revenue
336.79M EUR
Revenue Growth
+5.13%
P/S Ratio
2.30
Revenue / Employee
247.28K EUR
Employees
1,362
Market Cap
727.57M CHF
Revenue Chart
* This company reports financials in EUR.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 62.40B |
| Novartis AG | 43.89B |
| Lonza Group AG | 6.57B |
| Alcon | 8.77B |
| Galderma Group AG | 4.02B |
| Sandoz Group AG | 9.41B |
| Straumann Holding AG | 2.50B |
| Sonova Holding AG | 3.87B |